What I found in the existing data is that the metabolic improvements from retatrutide, including reduced visceral fat, lower triglycerides, and improved insulin sensitivity, all point toward a cardiovascular benefit profile rather than a risk profile
And at the forefront of this development is a drug called orforglipron
M., Barrett, C
Lacorte LH, Yanga JF, Samson KS, Aclibon YK, Buenaventura JN, Francis J (2022) Efficacy of flavonoids in increasing insulin sensitivity among pregnant women with gestational diabetes mellitus: a systematic review
Isabel Krug et al., Beyond Weight Loss: GLP1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes , 17 Nutrients 3735, 5 (2025), available at : (last visited Apr